Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Latest filing published 18 Jun 2026 for Ardelyx, INC.. Read the official filing
Filing timeline
BuySaleMerdad Parsey
Insider track record
Disclosed buys
0
Disclosed sells
9
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Merdad Parsey: trading record in brief
Filings by Merdad Parsey span 3 companies, the busiest being Gilead Sciences, Inc., Ardelyx, Inc. and Sagimet Biosciences Inc. The record holds 36 filings, for trades running from 15 August 2021 to 16 June 2026.
Sales make up the whole of the open-market record (9 sales, €2.2M). The rest of the record consists of 9 share grants and 17 option exercises.
The latest filing, published on 18 June 2026, reports a share grant in Ardelyx, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Merdad Parsey
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations36 total
26,455 sharesCommon StockSEC:0001792150-26-000002:0
15,235 shares0Common StockSEC:0001628280-25-032728:0
42,056 shares0Common StockSEC:0001628280-25-025641:0
3,820 sharesCommon StockSEC:0001127602-24-029171:0
57,294 shares@ US$57.9239.2% of flowCommon StockSEC:0001127602-24-028232:0
25,000 shares@ US$57.9216.4% of flowCommon StockSEC:0001127602-24-026735:0
2,000 shares@ US$83.831.9% of flowCommon StockSEC:0001127602-24-024958:0
25,000 shares@ US$57.9216.2% of flowCommon StockSEC:0001127602-24-023946:0
3,821 sharesCommon StockSEC:0001127602-24-023821:0
2,000 shares@ US$68.631.6% of flowCommon StockSEC:0001127602-24-019650:0
3,820 sharesCommon StockSEC:0001127602-24-018413:0
2,000 shares@ US$72.961.7% of flowCommon StockSEC:0001127602-24-011987:0
3,455 sharesCommon StockSEC:0001127602-24-009546:0
2,000 shares@ US$73.181.7% of flowCommon StockSEC:0001127602-24-007678:0
20,229 shares0Common StockSEC:0001127602-24-003044:0
2,779 sharesCommon StockSEC:0001127602-23-029247:0
1,501 shares@ US$76.991.3% of flowCommon StockSEC:0001127602-23-024115:0
2,779 sharesCommon StockSEC:0001127602-23-023979:0
8,677 sharesCommon StockSEC:0001104659-23-082729:0
1,485 shares@ US$76.901.3% of flowCommon StockSEC:0001127602-23-018727:0
2,779 sharesCommon StockSEC:0001127602-23-018588:0
6,126 shares@ US$78.995.6% of flowCommon StockSEC:0001127602-23-010126:0
3,455 sharesCommon StockSEC:0001127602-23-009986:0
12,984 shares@ US$79.961912.2% of flowCommon StockSEC:0001127602-23-008491:0
376 shares@ US$56.38050.2% of flowCommon StockSEC:0001127602-23-006763:0
25 of 36 declarations
